Evidence map›Paper›PMID 36421807›Full record

ArticleGenes2022

Analysis of

Alexander Refisch, Shoko Komatsuzaki, Martin Ungelenk, Andy Schumann, Ha-Yeun Chung, Susann S Schilling, Wibke Jantzen, Sabine Schröder, Markus M Nöthen, Thomas W Mühleisen and 2 more

Open access · goldAbstract read
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Alexander RefischDepartment of Psychiatry and Psychotherapy, Jena University Hospital, 07743 Jena, Germany.ORCID 0000-0002-3505-1575
Shoko KomatsuzakiInstitute of Human Genetics, Jena University Hospital, 07743 Jena, Germany.
Martin UngelenkInstitute of Human Genetics, Jena University Hospital, 07743 Jena, Germany.
Andy SchumannLab for Autonomic Neuroscience, Imaging and Cognition (LANIC), Department of Psychosomatic Medicine and Psychotherapy, Jena University Hospital, 07743 Jena, Germany.ORCID 0000-0002-5691-4325
Ha-Yeun ChungSection for Translational Neuroimmunology, Department of Neurology, Jena University Hospital, 07743 Jena, Germany.ORCID 0000-0002-6529-9176
Susann S SchillingLab for Autonomic Neuroscience, Imaging and Cognition (LANIC), Department of Psychosomatic Medicine and Psychotherapy, Jena University Hospital, 07743 Jena, Germany.
Wibke JantzenLab for Autonomic Neuroscience, Imaging and Cognition (LANIC), Department of Psychosomatic Medicine and Psychotherapy, Jena University Hospital, 07743 Jena, Germany.
Sabine SchröderLab for Autonomic Neuroscience, Imaging and Cognition (LANIC), Department of Psychosomatic Medicine and Psychotherapy, Jena University Hospital, 07743 Jena, Germany.
Markus M NöthenInstitute of Human Genetics, University of Bonn, 53113 Bonn, Germany.
Thomas W MühleisenInstitute of Neuroscience and Medicine (INM-1), Research Center Jülich, 52428 Jülich, Germany.ORCID 0000-0002-6057-5952
Christian A HübnerInstitute of Human Genetics, Jena University Hospital, 07743 Jena, Germany.
Karl-Jürgen BärLab for Autonomic Neuroscience, Imaging and Cognition (LANIC), Department of Psychosomatic Medicine and Psychotherapy, Jena University Hospital, 07743 Jena, Germany.ORCID 0000-0003-3861-5679
Jena University Hospital · DEForschungszentrum Jülich · DEUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiac autonomic dysfunction (CADF) is a major contributor to increased cardiac mortality in schizophrenia patients. The aberrant function of voltage-gated ion channels, which are widely distributed in the brain and heart, may link schizophrenia and CADF. In search of channel-encoding genes that are associated with both CADF and schizophrenia,

methodsFirst, we searched the literature for single-nucleotide polymorphisms (SNPs) in

resultsWe observed significantly increased QTvi in unmedicated patients with CADF-associated risk in

conclusionsWe propose a potential pleiotropic role for common variation in

Indexed as

Antipsychotic AgentsSchizophreniaCalcium Channels, L-TypeERG1 Potassium ChannelGenotypeHumansPolymorphism, Single NucleotideAntipsychotic AgentsCACNA1C protein, humanCalcium Channels, L-TypeERG1 Potassium ChannelKCNH2 protein, humanCACNA1Ccardiac autonomic dysfunctioncardiac mortalityheart rate variabilityKCNH2QT variabilityschizophreniavagal function

Identifiers

PMID36421807
PMCPMC9691174
OpenAlexW4309720502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.